Human herpesvirus-6: A short review of its biological behavior

Intervirology

Volumn 46, Issue 5, 2003, Pages 257-269

  Krueger, Gerhard R F ^a,c   Ablashi, Dharam V ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Advanced Biotechnologies Inc   (United States)

^c NONE   (Germany)

Author keywords

Clinical pathology; Epidemiology; HHV 6; Molecular biology

Indexed keywords

ACICLOVIR; ACYCLIC NUCLEOSIDE; AMPLIGEN; ANTIVIRUS AGENT; CELL RECEPTOR; CHEMOKINE; CYTOKINE; FOSCARNET; GANCICLOVIR; MEMBRANE COFACTOR PROTEIN; MEMBRANE RECEPTOR; NUCLEOSIDE ANALOG; PHOSPHONOACETIC ACID; RECOMBINANT GAMMA INTERFERON; VALACICLOVIR; VIRUS RECEPTOR;

ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ANTIMICROBIAL THERAPY; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CHILL; CLINICAL FEATURE; CONVULSION; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DIARRHEA; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; ENCEPHALITIS; FATIGUE; FEVER; FLU LIKE SYNDROME; HERPES SIMPLEX; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; IN VITRO STUDY; INFECTIOUS MONONUCLEOSIS; INTERSTITIAL PNEUMONIA; KIKUCHI DISEASE; LEUKOCYTOCLASTIC VASCULITIS; LIVER FAILURE; LYMPHATIC SYSTEM INFECTION; LYMPHOCYTOSIS; LYMPHOPROLIFERATIVE DISEASE; MALAISE; MENINGITIS; MOLECULAR BIOLOGY; MOLECULAR MIMICRY; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIPLE SCLEROSIS; OLIGODENDROGLIOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RASH; RECEPTOR UPREGULATION; SHORT SURVEY; SJOEGREN SYNDROME; SWEATING; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TISSUE DISTRIBUTION; VIRAL GENETICS; VIRUS CELL INTERACTION; VIRUS CLASSIFICATION; VIRUS MORPHOLOGY; VIRUS MYOCARDITIS; VIRUS PATHOGENESIS; VIRUS REACTIVATION;

ADULT; CELL LINE; CHILD; CHILD, PRESCHOOL; HERPESVIRUS 6, HUMAN; HUMANS; INFANT; ROSEOLOVIRUS INFECTIONS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 6;

EID: 0141992713     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073205     Document Type: Short Survey

References (174)

1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, Gallo RC: Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986;234:596-601.
2. Ablashi D, Agut H, Berneman Z, Campadelli-Fiume G, Carrigan D, Ceccerini-Nelli L, Chandran B, Chou S, Collandre H, Cone R, Dambaught T, Dewhurst S, DiLuca D, Foà-Tomasi L, Fleckenstein B, Frenkel N, Gallo R, Gompels U, Hall C, Jones M, Lawrence G, Martin M, Montagnier L, Neipel F, Nicholas J, Pellett P, Razzaque A, Torrelli G, Thomson B, Salahuddin S, Wyatt L, Yamanishi K: Human herpesvirus-6 strain groups: A nomenclature. Arch Virol 1993;129:363-366.
3. Downing RG, Sewankambo N, Serwadda D, Honess R, Crawford D, Jarrett R, Griffin BE: Isolation of human lymphotropic herpesviruses from Uganda. Lancet 1987;ii:390.
4. Lopez C, Pellett P, Stewart J, Goldsmith C, Sanderlin K, Black J, Warfield D, Feorino P: Characteristics of human herpesvirus-6. J Infect Dis 1988;157:1271-1273.
5. Braun DK, Dominguez G, Pellett PE: Human herpesvirus 6. Clin Microbiol Rev 1997;10:521-567.
6. Clark DA: Human herpesvirus 6. Rev Med Virol 2000;10:155-173.
7. Campadelli-Fiume G, Mirandola P, Menotti L: Human herpesvirus 6: An emerging pathogen. Emerg Infect Dis 1999;5:353-366.
8. Ablashi, DV, Krueger GRF, Salahuddin SZ: Human Herpesvirus-6. Amsterdam, Elsevier, 1992.
9. Yadav M, Umamaheswari S, Ablashi D: Antibody reactivity with two strains of human herpesvirus-6 in Malaysians. J Med Virol 1991;33:236-239.
10. Okuno T, Takahashi K, Balachandra K, Shiraki K, Yamanishi K, Takahashi M, Baba K: Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 1989;27:651-653.
11. Fox JD, Briggs M, Ward PA, Tedder RS: Human herpesvirus 6 in salivary glands. Lancet 1990;336:590-593.
12. Krueger GR, Wassermann K, De Clerck LS, Stevens WJ, Bourgeois N, Ablashi DV, Josephs SF, Balachandran N: Latent herpesvirus-6 in salivary and bronchial glands. Lancet 1990;336:1255-1256.
13. Cone RW, Huang ML, Hackman RC, Corey L: Coinfection with human herpesvirus 6 variants A and B in lung tissue. J Clin Microbiol 1996;34:877-881.
14. Krueger GRF, Sander C, Hoffmann A, Barth A, Koch B, Braun M: Isolation of human herpesvirus-6 (HHV-6) from patients with collagen vascular diseases. In Vivo 1991;5:217-226.
15. Ablashi DV, Balachandran N, Josephs SF, Hung CL, Krueger GR, Kramarsky B, Salahuddin SZ, Gallo RC: Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 1991;184:545-552.
16. Inoue N, Dambaugh TR, Pellett PE: Molecular biology of human herpesviruses 6A and 6B. Infect Agents Dis 1994;2:343-360.
17. Gompels UA, Nicholas J, Lawrence G, Jones M, Thomson BJ, Martin MED, Efstathiou S, Craxton M, Macaulay HA: The DNA sequence of human herpesvirus-6: Structure, coding content, and genome evolution. Virology 1995;209:29-51.
18. Dominguez G, Dambaugh TR, Stamey FR, Dewhurst S, Inoue N, Pellett PE: Human herpesvirus 6B genome sequence: Coding content and comparison with human herpesvirus 6A. J Virol 1999;73:8040-8052.
19. Isegawa Y, Mukai T, Nakano K, Kagawa M, Chen J, Mori Y, Sunagawa N, Kawanishi K, Sashihara J, Hata A, Zhou P, Kosuge H, Yamanishi K: Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol 1999;73:8053-8063.
20. Biberfeld P, Kramarski B, Salahuddin SZ, Gallo RC: Ultrastructural characterization of a new human B lymphotropic DNA virus (human herpesvirus 6) isolated from patients with lymphoproliferative disease. J Natl Cancer Inst 1987;79:933-941.
21. Kramarski B, Sander C: Electron microscopy of human herpesvirus-6 (HHV-6); in Ablashi DV, Krueger GRF, Salahuddin SZ: Human Herpesvirus 6. Amsterdam, Elsevier, 1992, pp 59-68.
22. Smith JD, De Harven E: Herpes simplex and human cytomegalovirus replication in WI-38 cells. Sequence of viral replication. J Virol 1973;12:919-930.
23. Heine U, Cottler-Fox M: Electron microscopic observations on the composition of herpes-type virions; in deThe G, Epstein MA, zur Hausen H: Oncogenesis and Herpesviruses II. IARC Publ No 11, Lyon, International Agency for Research on Cancer, 1975, pp 103-110.
24. Nii S, Uno F, Yoshida M, Akatsuka K: Structure and assembly of human beta herpesviruses (in Japanese). Nippon Rinsho 1998;65:22-28.
25. Torrisi MR, Gentile M, Cardinali G, Cirone M, Zompetta C, Lotti LV, Frati L, Faggioni A: Intracellular transport and maturation pathway of human herpesvirus 6. Virology 1999;257:460-471.
26. Hong ZH, Krueger GRF: Structure and replication of human herpesviruses. J Cell Mol Biol, submitted.
27. Chen DH, Jiang H, Lee M, Liu F, Zhou HZ: Three-dimensional visualization of tegument/capsid interactions in the intact human cytomegalovirus. Virology 1999;260:10-16.
28. Balachandran N: Proteins of human herpesvirus-6; in Ablashi DV, Krueger GRF, Salahuddin SZ: Human Herpesvirus-6. Amsterdam, Elsevier, 1992, pp 97-120.
29. Taniguchi T, Shimamoto T, Isegawa Y, Kondo K, Yamanishi K: Structure of transcription and proteins encoded by U79-80 of human herpesvirus 6 and its subcellular localization in infected cells. Virology 2000;271:307-320.
30. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P: CD46 is a cellular receptor for human herpesvirus 6. Cell 1999;99:817-827.
31. Boehmer S: Biologischer Effekt des humanen Herpesvirus-6 (HHV-6) auf Zellpopulationen unterschiedlichen Phänotyps; thesis, University of Cologne. Cologne, Hundt, 1997, pp 1-219.
32. Klueppelberg U: Der systemische Lupus erythematodes (SLE): Übersicht und eigene Arbeiten zur Herpesvirus-6 Infektion; thesis, University of Cologne. Cologne, Hundt, 1994, pp 1-95.
33. Flamand L, Gosselin J, Stefanescu I, Ablashi D, Menezes J: Immunosuppressive effect of human herpesvirus 6 on T-cell functions: Suppression of interleukin-2 synthesis and cell proliferation. Blood 1995;85:1263-1271.
34. Salahuddin SZ, Kelley AS, Krueger GRF, Josephs SF, Gupta S, Ablashi DV: Human herpesvirus 6 (HHV-6) in diseases. Clin Diag Virol 1993;1:81-100.
35. Krueger GR, Klueppelberg U, Hoffmann A, Ablashi DV: Clinical correlates of infection with human herpesvirus-6. In Vivo 1994;8:457-485.
36. Yoshikawa T, Asano Y: Central nervous system complications in human herpesvirus-6 infection. Brain Dev 2000;22:307-314.
37. Krueger GR, Ferrer Argote V: A unifying concept of viral immunopathogenesis of proliferative and aproliferative diseases (working hypothesis). In Vivo 1994;8:493-499.
38. Greenstone HL, Santoro F, Lusso P, Berger FA: Human herpesvirus 6 and measles virus employ distinct CD46 domains for receptor function. J Biol Chem 2002;277:39112-39118.
39. Mori Y, Yang X, Akkapaiboon P, Okuno T, Yamanishi K: Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J Virol 2003;77:4992-4999.
40. Wagner M, Krueger GRF, Ablashi DV, Whitman JE: Chronic fatigue syndrome (CFS): A critical evaluation of testing for active human herpesvirus-6 (HHV-6) infection: Review of data from 107 cases. J Chron Fatigue Syndr 1996;2:3-16.
41. Krueger GR, Manak M, Bourgeois N, Ablashi DV, Salahuddin SZ, Josephs SS, Buchbinder A, Gallo RC, Berthold F, Tesch H: Persistent active herpes virus infection associated with atypical polyclonal lymphoproliferation (APL) and malignant lymphoma. Anticancer Res 1989;9:1457-1476.
42. Wiersbitzky S, Ratzmann GW, Bruns R, Wiersbitzky H: Reactivation in children of juvenile chronic arthritis and chronic iridocyclitis associated with human herpesvirus-6. Pädiatr Grenzgeb 1993;31:203-205.
43. Buchwald D, Cheney PR, Peterson DL, Henry B, Wormsley SB, Geiger A, Ablashi DV, Salahuddin SZ, Saxinger C, Biddle R: A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med 1992;116:103-113.
44. Reeves WC, Stamey FR, Black JB, Mawle AC, Stewart JA, Pellett PE: Human herpesviruses 6 and 7 in chronic fatigue syndrome: A case-control study. Clin Infect Dis 2000;31:48-52.
45. Enbom M, Linde A, Evengard B: No evidence of active infection with human herpesvirus 6 (HHV-6) or HHV-8 in chronic fatigue syndrome. J Clin Microbiol 2000;38:2457.
46. Prezioso PJ, Cangiarella J, Lee M, Nuovo GJ, Borkowsky W, Orlow SJ, Greco MA: Fatal disseminated infection with human herpesvirus-6. J Pediatr 1992;120:921-923.
47. Hall CB, Long CE, Schnabel KC, Caserta MT, McIntyre KM, Costanzo MA, Knott A, Dewhurst S, Insel RA, Epstein LG: Human herpes-virus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 1994;331:432-438.
48. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T: Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988;i:1065-1067.
49. Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T, Kajita Y, Ozaki T: Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics 1994;93:104-108.
50. Lasch JA, Klussmann JP, Krueger GR: Die humanen Herpesviren 6 und 7. Hautarzt 1996;47:341-350.
51. Krueger GRF, Bertram G, Ramon A, Koch B, Ablashi DV, Brandt ME, Wang G, Buja LM: Dynamics of infection with human herpesvirus-6 in EBV-negative infectious mononucleosis: Data acquisition for computer modeling. In Vivo 2001;15:373-380.
52. Krueger GRF, Koch B, Hoffmann A, Rojo J, Brandt ME, Wang G, Buja LM: Dynamics of chronic active herpesvirus-6 infection in patients with chronic fatigue syndrome: Data acquisition for computer modeling. In Vivo 2001;15:461-466.
53. Krueger GRF, Brandt ME, Wang G, Buja LM: TCM-1:A non-linear dynamical computational model to simulate cellular changes in the T cell system: Conceptional design and validation. Anticancer Res 2003;23:123-136.
54. Wang G, Krueger GRF, Buja LM: A mathematical model to simulate cellular dynamics of infection with human herpesvirus-6 in EBV-negative infectious mononucleosis. J Med Virol, in print.
55. Krueger GRF, Brandt ME, Wang G, Berthold F, Buja LM: A computational analysis of Canale-Smith syndrome: Chronic lymphadenopathy simulating malignant lymphoma. Anticancer Res 2002;22:2365-2372.
56. Sumiyoshi Y, Kikuchi M, Ohshima K, Yoneda S, Kobari S, Takeshita M, Eizuru Y, Minamishima Y: Human herpesvirus-6 genomes in histiocytic necrotizing lymphadenitis (Kikuchi's disease) and other forms of lymphadenitis. Am J Clin Pathol 1993;99:609-614.
57. Krueger GR, Huetter ML, Rojo J, Romero M, Cruz-Ortiz H: Human herpesviruses HHV-4 (EBV) and HHV-6 in Hodgkin's and Kikuchi's diseases and their relation to proliferation and apoptosis. Anticancer Res 2001;21:2155-2161.
58. Dominguez DC, Torres ML, Antony S: Is human herpesvirus 6 linked to Kikuchi-Fujimoto disease? The importance of consistent molecular and serologic analysis. South Med J 2003;96:226-233.
59. Steeper TA, Horwitz CA, Ablashi DV, Salahuddin SZ, Saxinger C, Saltzman R, Schwartz B: The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus. Am J Clin Pathol 1990;93:776-783.
60. Akashi K, Eizuru Y, Sumiyoshi Y, Minematsu T, Hara S, Harada M, Kikuchi M, Niho Y, Minamishima Y: Brief report: Severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med 1993;329:168-171.
61. Bertram G, Dreiner N, Krueger GR, Ramon A, Ablashi DV, Salahuddin SZ, Balachandram N: Frequent double infection with Epstein-Barr virus and human herpesvirus-6 in patients with acute infectious mononucleosis. In Vivo 1991;5:271-279.
62. Luppi M, Marasca R, Barozzi P, Artusi T, Torelli G: Frequent detection of human herpesvirus-6 sequences by polymerase chain reaction in paraffin-embedded lymph nodes from patients with angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Leuk Res 1993;17:1003-1011.
63. Daibata M, Ido E, Murakami K, Kuzume T, Kubonishi I, Taguchi H, Miyoshi I: Angioimmunoblastic lymphadenopathy with disseminated human herpesvirus 6 infection in a patient with acute myeloblastic leukemia. Leukemia 1997;11:882-885.
64. Sugita K, Kurumada H, Eguchi M, Furukawa T: Human herpesvirus 6 infection associated with hemophagocytic syndrome. Acta Haematol 1995;93:108-109.
65. Tanaka H, Nishimura T, Hakui M, Sugimoto H, Tanaka-Taya K, Yamanishi K: Human herpesvirus 6-associated hemophagocytic syndrome in a healthy adult. Emerg Infect Dis 2000;8:87-88.
66. Leahy MA, Krejci SM, Friednash M, Stockert SS, Wilson H, Huff JC, Weston WL, Brice SL: Human herpesvirus 6 is present in lesions of Langerhans cell histiocytosis. J Invest Dermatol 1993;101:642-645.
67. Torelli G, Marasca R, Luppi M, Selleri L, Ferrari S, Narni F, Mariano MT, Federico M, Ceccherini-Nelli L, Bendinelli M, Montagnani G, Montorsi M, Artusi T: Human herpesvirus-6 in human lymphomas: Identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction. Blood 1991;77:2251-2258.
68. Di Luca D, Dolcetti R, Mirandola P, De Re V, Secchiero P, Carbone A, Boiocchi M, Cassai E: Human herpesvirus 6:A survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders. J Infect Dis 1994;170:211-215.
69. Razzaque A, Francillon Y, Jilly PN, Varricchio F: Detection of human herpesvirus 6 sequences in lymphoma tissues by immunohistochemistry and polymerase chain reactions. Cancer Lett 1996;106:221-226.
70. Bandobashi K, Daibata M, Kamioka M, Tanaka Y, Kubonishi I, Taguchi H, Ohtsuki Y, Miyoshi I: Human herpesvirus 6 (HHV-6)-positive Burkitt's lymphoma: Establishment of a novel cell line infected with HHV-6. Blood 1997;90:1200-1207.
71. Braun DK, Pellett PE, Hanson CA: Presence and expression of human herpesvirus 6 in peripheral blood mononuclear cells of S100-positive, T cell chronic lymphoproliferative disease. J Infect Dis 1995;171:1351-1355.
72. Lin WC, Moore JO, Mann KP, Traweek ST, Smith C: Post transplant CD8+γδ T-cell lymphoma associated with human herpes virus-6 infection. Leuk Lymphoma 1999;33:377-384.
73. Hallas C, Neipel F, Huettner C, Schreiner D, Fleckenstein B, Muller-Hermelink HK: Presence of human herpesvirus type 6 in sporadic lymphoproliferative disorders. A comparative study. Diagn Mol Pathol 1996;5:166-172.
74. Luppi M, Barozzi P, Garber R, Maiorana A, Bonacorsi G, Artusi T, Trovato R, Marasca R, Torelli G: Expression of human herpesvirus-6 antigens in benign and malignant lymphopro-liferative diseases. Am J Pathol 1998;153:815-823.
75. Hermouet S, Sutton CA, Rose TM, Greenblatt RJ, Corre I, Garand R, Neves AM, Bataille R, Casey JW: Qualitative and quantitative analysis of human herpesviruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma. Leukemia 2003;17:185-195.
76. Razzaque A: Oncogenic potential of human herpesvirus-6 DNA. Oncogene 1990;5:1365-1370.
77. Thompson J, Choudhury S, Kashanchi F, Doniger J, Berneman Z, Frenkel N, Rosenthal LJ: A transforming fragment within the direct repeat region of human herpesvirus type 6 that transactivates HIV-1. Oncogene 1994;9:1167-1175.
78. Kakimoto M, Hasegawa A, Fujita S, Yasukawa M: Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection. J Virol 2002;76:10338-10345.
79. Carrigan DR, Knox KK: Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients. Blood 1994;84:3307-3310.
80. Singh N, Carrigan DR: Human herpesvirus-6 in transplantation: An emerging pathogen. Ann Intern Med 1996;124:1065-1071.
81. Isomura H, Yamada M, Yoshida M, Tanaka H, Kitamura T, Oda M, Nii S, Seino Y: Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells. J Med Virol 1997;52:406-412.
82. Penchansky L, Jordan JA: Transient erythroblastopenia of childhood associated with human herpesvirus type 6, variant B. Am J Clin Pathol 1997;108:127-132.
83. Wang FZ, Linde A, Dahl H, Ljungman P: Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation. Bone Marrow Transplant 1999;24:1201-1206.
84. Rosenfeld CS, Rybka WB, Weinbaum D, Carrigan DR, Knox KK, Andrews DF, Shadduck RK: Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Exp Hematol 1995;23:626-629.
85. Lau YL, Peiris M, Chan GC, Chan AC, Chiu D, Ha SY: Primary human herpes virus 6 infection transmitted from donor to recipient through bone marrow infusion. Bone Marrow Transplant 1998;21:1063-1066.
86. Herbein G, Strasswimmer J, Altieri M, Woehl-Jaegle ML, Wolf P, Obert G: Longitudinal study of human herpesvirus 6 infection in organ transplant recipients. Clin Infect Dis 1996;22:171-173.
87. Clark DA: Human herpesvirus 6 and human herpesvirus 7: Emerging pathogens in transplant patients. Int J Hematol 2002;76(suppl 2):246-252.
88. Sashihara J, Tanaka-Taya K, Tanaka S, Amo K, Miyagawa H, Hosoi G, Tanuguchi T, Fukui T, Kasuga N, Aono T, Sako M, Hara J, Yamanishi R, Okada S: High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 2002;100:2005-2011.
89. Ihara M, Yoshikawa T, Suzuki K, Ohashi M, Suga S, Horibe K, Tanaka S, Kimura H, Kojima S, Kato K, Matsuyama T, Nishiyama Y, Asano Y: Monitoring of active HHV-6 infection in bone marrow transplant recipients by real time PCR: Comparison to detection of viral DNA in plasma by qualitative PCR. Microbiol Immunol 2002;46:701-705.
90. Boutolleau D, Fernandez C, André E, Imbert-Marcille BM, Milpied N, Agut H, Gautheret-Dejean A: Human herpesvirus (HHV)-6 and HHV-7: Two closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 2003;187:179-186.
91. Yoshikawa T: Human herpesvirus-6 and -7 infections in transplantation. Pediatr Transplant 2003;7:11-17.
92. Clark DA, Emery VC, Griffith PD: Cytomegalovirus, human herpesvirus-6 and human herpesvirus-7 in hematological patients. Semin Hematol 2003;40:154-162.
93. Feldstein AE, Razonable RR, Boyce TG, Freese DK, El-Youssef M, Perrault J, Paya CV, Ishitani MB: Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients. Pediatr Transplant 2003;7:125-129.
94. Kaden J, May G, Wagner M, Krueger GRF: Nachweis von Antikörpern gegen humanes Herpesvirus-6 (HHV-6) bei Nierentransplantatempfängern mit Cytomegalovirus (CMV)-Infektion. Transplantationsmedizin 1997;9:28-32.
95. Krueger GRF, Kudlimay D, Ramon A, Klueppelberg U, Schumacher K: Demonstration of active and latent Epstein-Barr virus and human herpesvirus-6 infections in bone marrow cells of patients with myelodysplasia and chronic myeloproliferative diseases. In Vivo 1994;8:533-542.
96. Rojo J, Cruz-Ortiz H, Krueger GRF: Los virus herpes linfotrópicos humanos: Epstein-Barr (VEB), 6 y 7 (HHV-6 y HHV-7) en la patogenia de enfermedades mielodisplásicas (SMDñ) y mieloproliferativas (SMP). Rev Med Hosp Gen Mexico 2000;63:18-24.
97. Descamps V, Bouscarat F, Laglenne S, Aslangul E, Veber B, Descamps D, Saraux JL, Grange MJ, Grossin M, Navratil E, Crickx B, Belaich S: Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997;137:605-608.
98. Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, Hashimoto K: Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998;134:1113-1117.
99. Conilleau V, Dompmartin A, Verneuil L, Michel M, Leroy D: Hypersensitivity syndrome due to 2 anticonvulsant drugs. Contact Dermatitis 1999;41:141-144.
100. Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, Belaich S, Crickx B: Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001;137:301-304.
101. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T: Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998;134:1108-1112.
102. Lusso P: Target cells for infection; in Ablashi DV, Krueger GRF, Salahuddin SZ: Human Herpesvirus-6. Amsterdam, Elsevier, 1992, pp 25-36.
103. Cuomo L, Trivedi P, Cardillo MR, Gagliardi FM, Vecchione A, Caruso R, Calogero A, Frati F, Faggioni A, Ragona G: Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol 2001;63:45-51.
104. Hall CB, Caserta MT, Schnabel KC, Long C, Epstein LG, Insel RA, Dewhurst S: Persistence of human herpesvirus 6 according to site and variant: Possible greater neurotropism of variant A. Clin Infect Dis 1998;26:132-137.
105. Luppi M, Barozzi P, Maiorana A, Marasca R, Trovato R, Fano R, Ceccherini-Nelli L, Torelli G: Human herpesvirus-6:A survey of presence and distribution of genomic sequences in normal brain and neuroglial tumors. J Med Virol 1995;47:105-111.
106. Caserta MT, Hall CB, Schnabel K, McIntire K, Long C, Costanzo M, Dewhurst S, Insel R, Epstein LG: Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994;170:1586-1589.
107. Wilborn F, Schmidt CA, Brinkmann V, Jendroschka K, Ottle H, Siegert W: A potential role for human herpesvirus type 6 in nervous system disease. J Neuroimmunol 1994;49:213-214.
108. Knox KK, Carrigan DR: Active human herpesvirus 6 (HHV-6) infection of the central nervous system in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:66-73.
109. Bonthius DJ, Karacay B: Meningitis and encephalitis in children. An update (review). Neurol Clin 2002;20:1013-1038.
110. Eeg-Olofsson O: Virological and immunological aspects of seizure disorders. Brain Dev 2003;25:9-13.
111. Wagner M, Müller-Berghaus J, Schroeder R, Sollberg S, Luka J, Leyssens N, Schneider B, Krueger GRF: Human herpesvirus-6 (HHV-6) associated necrotizing encephalitis in Griscelli's syndrome. J Med Virol 1997;53:306-312.
112. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M, Schad PA, Stewart PM, Nowinski RC, Brown JP, Burmer GC: Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995;92:7440-7444.
113. Solldan SS, Leist TP, Juhng KN, McFarland HF, Jacobson S: Increased lymphoproliferative response to human herpesvirus type 6A in multiple sclerosis. Ann Neurol 2000;47:306-313.
114. An SF, Groves M, Martinian L, Kuo LT, Scaravilli F: Detection of infectious agents in brain of patients with acute hemorrhagic leukoencephalitis. J Neurovirol 2002;8:439-446.
115. Cirone M, Cuomo L, Zompetta C, Ruggieri S, Frati L, Faggioni A, Rago G: Human herpesvirus 6 and multiple sclerosis: A study of T cell cross-reactivity to viral and myelin basic protein antigens. J Med Virol 2002;68:268-272.
116. Chapenko S, Millers A, Nora Z, Logina I, Kukaine R, Murovska M: Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J Med Virol 2003;69:111-117.
117. Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Zhang JZ: Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 2003;53:189-197.
118. Pruitt AA: Nervous system infections in patients with cancer. Neurol Clin 2003;21:193-219.
119. Stodberg T, Deniz Y, Esteitie N, Jacobsson B, Mousavi-Jazi M, Dahl H, Zweyberg Wirgart B, Grillner L, Linde A: A case of diffuse leptomeningeal oligodendrogliomatosis associated with HHV-6 variant A. Neuropediatrics 2002;33:266-270.
120. Rotola A, DiLuca D, Cassai E, Giulio A, Turano A, Caruso A, Muneretto C: Human herpesvirus 6 infects and replicates in aortic endothelium. J Clin Microbiol 2000;38:3135-3136.
121. Wu CA, Shanley JD: Chronic infection of human umbilical vein endothelial cells by human herpesvirus-6. J Gen Virol 1998;79:1247-1256.
122. Takatsuka H, Wakae T, Mori A, Okada M, Fujimori Y, Takemoto Y, Okamoto T, Kanamaru A, Kakishita E: Endothelial damage caused by cytomegalovirus and human herpesvirus-6. Bone Marrow Transplant 2003;31:475-479.
123. Toyabe S, Harada W, Suzuki H, Hirokawa T, Uchiyama M: Large vessel arteritis associated with human herpesvirus 6 infections. Clin Rheumatol 2002;21:528-532.
124. Drago F, Rampini P, Brusati C, Rebora A: Leukocytoclastic vasculitis in a patient with HHV-6 infection. Acta Derm Venereol (Stockh) 1999;80:68.
125. Hagiwara K, Yoshida T, Komura H, Kishi F, Kajii T: Isolation of human herpesvirus-6 from an infant with Kawasaki's disease. Eur J Pediatr 1993;152:176.
126. Luka J, Gubin J, Afflerbach C, Carson SD, Krueger GRF: Detection of human herpesvirus-6 (HHV-6) genome by in situ PCR in tissues from Kawasaki disease and in coronary arteries of transplant hearts (abstract). 3rd Int Conf Modern Methods in Analytical Morphology, Atlantic City, June 1995.
127. Yoshikawa T, Akimoto S, Nishimura N, Ozaki T, Ihira M, Ohashi M, Morooka M, Suga S, Asano Y, Takemoto M, Nishiyama Y: Evaluation of active human herpesvirus 6 infection by reverse transcription-PCR. J Med Virol 2003;70:267-272.
128. Fukae S, Ashizawa N, Morikawa S, Yano K: A fatal case of fulminant myocarditis with human herpesvirus-6 infection. Intern Med 2000;39:632-636.
129. Cone RW, Hackman RC, Meei-Li WH, Bowden RA, Meyers JD, Metcalf M, Zeh J, Ashley R, Corey L: Human herpesvirus 6 in lung tissue from patients with peumonitis after bone marrow transplantation. N Engl J Med 1993;329:156-161.
130. Know KK, Pietryga D, Harrington DJ, Franciosi R, Carrigan DR: Progressive immunodeficiency and fetal pneumonitis associated with human herpesvirus-6 infection in an infant. Clin Infect Dis 1995;20:406-413.
131. Aita K, Jin Y, Irie H, Takahashi I, Kobori K, Nakasato Y, Kodama H, Yanagawa Y, Yoshikawa T, Shiga J: Are there histopathological characteristics particular to fulminant hepatic failure caused by human herpesvirus-6 infection? A case report and discussion. Hum Pathol 2001;32:887-889.
132. Ishikawa K, Hasegawa K, Naritomi T, Kanai N, Ogawa M, Kato Y, Kobayashi M, Torii N, Hayashi N: Prevalence of herpesviridae and hepatitis virus sequences in the livers of patients with fulminant hepatitis of unknown etiology in Japan. J Gastroenterol 2002;37:523-530.
133. Amo K, Tanaka-Taya K, Inagi R, Miyagawa H, Miyoshi H, Okusu I, Sashihara J, Hara J, Nakayama M, Yamanishi K, Okada S: Human herpesvirus 6B infection of the large intestine of patients with diarrhea. Clin Infect Dis 2003;36:120-123.
134. Lusso P, Ablashi DV, Luka J: Interaction between HHV-6 and other viruses; in Ablashi DV, Krueger GRF, Salahuddin SZ: Human herpesvirus-6. Amsterdam, Elsevier, 1992, pp 121-133.
135. Flamand L, Stefanescu L, Ablashi DV, Menezes J: Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6. J Virol 1993;67:6768-6777.
136. al-Kaldi N, Watson AR, Harris A, Irving WL: Dual infection with human herpesvirus type 6 and parvovirus B19 in a renal transplant recipient. Pediatr Nephrol 1994;8:349-350.
137. Chen M, Wang H, Woodworth CD, Lusso P, Berneman Z, Kingsma D, Delgado G, DiPaolo JA: Detection of human herpesvirus 6 and human papillomavirus 16 in cervical carcinoma. Am J Pathol 1994;145:1509-1516.
138. Lusso P, Garzino-Demo A, Crowley RW, Malnati MS: Infection of γ/δ T lymphocytes by human herpesvirus-6: Transcriptional induction of CD4 and susceptibility to HIV infection. J Exp Med 1995:181:1303-1310.
139. Ablashi DV, Bernbaum J, DiPaolo JA: Human herpesvirus 6 as copathogen. Trends Immunobiol 1995;3:324-326.
140. Como L, Trivedi P, deGarzia U, Colagero A, D'Onofrio M, Yang W, Frati L, Faggioni A, Rymo L, Ragona G: Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells. J Med Virol 1998;55:219-226.
141. Singh VK, Lin SX, Yang VC: Serological association of measles virus and human herpesvirus-6 with brain antibodies and autism. Clin Immunol Immunopathol 1998;89:105-108.
142. Williams MV: HHV-6: Response to antiviral agents; in Ablashi DV, Krueger GRF, Salahuddin SZ (eds): Human Herpesvirus-6: Epidemiology, Molecular Biology and Clinical Pathology. Amsterdam, Elsevier, 1992, pp 317-335.
143. De Clercq E, Naesens L, De Bolle L, Schols D, Zhang Y, Neyts J: Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev Med Virol 2001;11:381-395.
144. Zerr DM, Gupta D, Huang ML, Carter R, Corey L: Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002;34:309-317.
145. Clark DA, Griffith PD: Human herpesvirus 6: Relevance of infection in the immunocompromised host. Br J Haematol 2003;120:384-395.
146. Rapaport D, Engelhard D, Tagger G, Or R, Frenkel N: Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transpl Infect Dis 2002;4:10-16.
147. Mookerjee BP, Vogelsang G: Human herpesvirus-6 encephalitis after bone marrow transplantation: Successful treatment with gancyclovir. Bone Marrow Transplant 1997;20:905-906.
148. Griffiths PD: Tomorrow's challenges for herpesvirus management: Potential applications of valacyclovir. J Infect Dis 2002;186(suppl 2):S131-S137.
149. Streicher HZ, Hung CL, Ablashi DV, Hellman K, Saxinger C, Fullen J, Salahuddin SZ: In vitro inhibition of human herpesvirus-6 by phosphonoformate. J Virol Methods 1988;21:301-304.
150. Hong J, Tejada-Simon MV, Rivera VM, Zang YC, Zhang JZ: Antiviral properties of interferon beta treatment in patients with multiple sclerosis. Mult Scler 2002;8:237-242.
151. Yamanishi K, DeClerck E: Selective activity of various nucleoside analogues against herpesvirus 6 and 7. Antivir Chem Chemother 1997;8:24-31.
152. Reymen D, Naessens L, Balzarini J, Holy A, Dvosakova H, DeClerck E: Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Res 1995;28:343-357.
153. Strayer DR, Carter W, Straus KL, Brodsky I, Suhadolnik RJ, Ablashi DV, Henry B, Michell WM, Bastien S, Peterson D: Long-term improvements in patients with chronic fatigue syndrome treated with Ampligen. J CFS 1995;1:35-53.
154. Ablashi DV, Berneman ZN, Williams M, Strayer DR, Kramarsky B, Suhadolnik RJ, Reichenbach N, Hiltzges P, Komaroff AL: Ampligen inhibits human herpesvirus-6 in vitro. In Vivo 1994;8:587-591.
155. Ablashi DV, Levine PH, De Vinci C, Whitman JE Jr, Pizza G, Viza D: Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports. Biotherapy 1996;9:81-86.
156. Dockrell DH: Human herpesvirus 6: Molecular biology and clinical features. J Med Microbiol 2003;52:5-18.
157. Furukawa M, Yasukawa M, Yakushijin Y, Fujita S: Distinct effects of human herpesvirus 6 and human herpesvirus 7 on surface molecule expression and function of CD4+ T cells. J Immunol 1994;152:5768-5775.
158. Arena A, Stassi G, Speranza A, Iannello D, Mastroeni P: Modulatory effect of HHV-6 on MCP-1 production by human monocytes. New Microbiol 2002;25:335-340.
159. Isegawa Y, Ping Z, Nakano K, Sugimoto N, Yamanishi K: Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor. J Virol 1998;72:6104-6112.
160. Arena A, Liberto MC, Iannello D, Capozza AB, Foca A: Altered cytokine production after human herpes virus type 6 infection. New Microbiol 1999;22:293-300.
161. Arena A, Iannello D, Gazzara D, Speranza A, Bonina L, Mastroeni P: Role of interleukin-18 in peripheral blood mononuclear cells infected with human herpes virus type 6. Intervirology 2001;44:250-254.
162. Milne RS, Mattick C, Nicholson L, Devaraj P, Alcami A, Gompels UA: RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor. J Immunol 2000;164:2396-2404.
163. Vignoli M, Furlini G, Re MC, Ramazzotti E, La Placa M: Modulation of CD4, CXCR4, and CCR-5 makes human hematopoietic progenitor cell lines infected with human herpesvirus-6 susceptible to human immunodeficiency virus type 1. J Hematother Stem Cell Res 2000;9:39-45.
164. Gosselin J, Flamand L, D'Addario M, Hiscott J, Stefanescu I, Ablashi DV, Gallo RC, Menezes J: Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A
165. Murphy PM: Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2001;2:116-122.
166. Lusso P, Malnati M, DeMaria A, Balotta C, DeRocco SE, Markham PD, Gallo RC: Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J Immunol 1991;147:685-691.
167. Farber I, Wutzler P: FC receptor induced by human herpesvirus-6. Acta Virol 1991;25:400.
168. Hasegawa A, Yasukawa M, Sakai I, Fujita S: Transcriptional down-regulation of CXC chemokine receptor 4 induced impaired association of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells. J Immunol 2001;166:1125-1131.
169. Kirn E, Krueger E, Boehmer S, Klussmann JP, Krueger GRF: In vitro cytobiological effects of human herpesvirus 6 and 7: Immunohistological monitoring of apoptosis, differentiation and cell proliferation. Anticancer Res 1997;17:4623-4632.
170. Eichler F, Krueger GRF: Effects of non-specific immunostimulants (echinacin, isoprinosine and thymus factors) on the infection and antigen expression in herpesvirus-6 exposed human lymphoid cells. In Vivo 1994;8:565-575.
171. Hirata Y, Kondo K, Yamanishi K: Human herpesvirus 6 down-regulates major histocompatibility complex class I in dendritic cells. J Med Virol 2001;65:576-583.
172. Lautenschlager I, Harma M, Hockerstedt K, Linnavuori K, Loginov R, Taskinen E: Human herpesvirus-6 infection is associated with adhesion molecule induction and lymphocyte infiltration in liver allografts. J Hepatol 2002;37:648-654.
173. Deliconstantinos G, Buja LM, Rojo J, Krueger GRF: Human herpesvirus-6 (HHV-6) induced cytopathology: Cell membrane fluidity, oxidative burst and apoptosis. Rev Med Hosp Gen Mexico 1998;61:211-217.
174. Miyata M, Kasukawa R: Rheumatoid factor: A review of the mode of formation and role in transplantation. Fukushima J Med Sci 1993;39:15-28.